美年健康
(002044)
| 流通市值：179.76亿 | | | 总市值：181.62亿 |
| 流通股本：38.74亿 | | | 总股本：39.14亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,844,337,529.39 | 1,583,788,046.28 | 10,359,530,671.3 | 6,925,390,135.63 |
| 营业收入 | 3,844,337,529.39 | 1,583,788,046.28 | 10,359,530,671.3 | 6,925,390,135.63 |
| 二、营业总成本 | 4,017,985,717.72 | 1,886,216,163.78 | 9,639,113,427.74 | 6,747,899,733.5 |
| 营业成本 | 2,541,292,544.71 | 1,177,669,060.87 | 6,074,908,557.69 | 4,270,857,332.19 |
| 税金及附加 | 2,944,211.44 | 1,178,983.76 | 8,189,315.54 | 4,083,846.66 |
| 销售费用 | 912,842,790.12 | 420,758,331.19 | 2,341,119,289.1 | 1,573,220,297.44 |
| 管理费用 | 398,005,061.65 | 205,610,714.26 | 860,133,225.44 | 633,221,283.2 |
| 研发费用 | 27,377,003.51 | 12,087,359.76 | 52,689,620.06 | 36,848,699.31 |
| 财务费用 | 135,524,106.29 | 68,911,713.94 | 302,073,419.91 | 229,668,274.7 |
| 其中:利息费用 | 135,636,207.52 | 69,747,764.83 | 304,384,192.87 | 232,089,210.08 |
| 其中:利息收入 | 4,318,586.1 | 2,183,243.29 | 10,859,299.51 | 8,320,533.46 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -5,494,659.41 | -5,170,691.57 | 25,429,541.8 | 32,496,984.97 |
| 加:投资收益 | -9,072,061.75 | -4,988,338.94 | 35,132,537.76 | 634,287.97 |
| 资产处置收益 | -604,575.53 | -834,227.98 | -10,204,107.92 | -8,508,996.83 |
| 资产减值损失(新) | - | - | -60,051,831.96 | - |
| 信用减值损失(新) | -21,125,450.1 | 13,104,229.4 | -139,154,669.58 | -55,427,748.88 |
| 其他收益 | 19,451,217.58 | 5,484,840.24 | 26,254,814.19 | 17,231,945.9 |
| 四、营业利润 | -190,493,717.54 | -294,832,306.35 | 597,823,527.85 | 163,916,875.26 |
| 加:营业外收入 | 22,490,008.67 | 7,279,831.45 | 21,931,267.19 | 4,626,884.09 |
| 减:营业外支出 | 21,494,703.11 | 12,574,622.7 | 62,303,948.31 | 30,216,263.55 |
| 五、利润总额 | -189,498,411.98 | -300,127,097.6 | 557,450,846.73 | 138,327,495.8 |
| 减:所得税费用 | 2,184,701.12 | -31,322,392.9 | 186,866,034.63 | 46,867,380.06 |
| 六、净利润 | -191,683,113.1 | -268,804,704.7 | 370,584,812.1 | 91,460,115.74 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -191,683,113.1 | -268,804,704.7 | 370,584,812.1 | 91,460,115.74 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -182,388,732.05 | -255,039,233.23 | 285,327,021.07 | 51,859,853.32 |
| 少数股东损益 | -9,294,381.05 | -13,765,471.47 | 85,257,791.03 | 39,600,262.42 |
| 扣除非经常损益后的净利润 | -206,951,047.92 | -259,887,341.08 | 258,287,037.01 | 12,228,899.05 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.05 | -0.07 | 0.07 | 0.01 |
| (二)稀释每股收益 | -0.05 | -0.07 | 0.07 | 0.01 |
| 八、其他综合收益 | -221,466.5 | -120,928.37 | -227,114.9 | -116,396.64 |
| 归属于母公司股东的其他综合收益 | 44,344.31 | 29,063.05 | -48,223.32 | -17,533.88 |
| 九、综合收益总额 | -191,904,579.6 | -268,925,633.07 | 370,357,697.2 | 91,343,719.1 |
| 归属于母公司股东的综合收益总额 | -182,344,387.74 | -255,010,170.18 | 285,278,797.75 | 51,842,319.44 |
| 归属于少数股东的综合收益总额 | -9,560,191.86 | -13,915,462.89 | 85,078,899.45 | 39,501,399.66 |
| 公告日期 | 2026-08-31 | 2026-04-30 | 2026-04-28 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |